9
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7356 |
PTP1B-IN-1
PTP1B inhibitor,5-苯基-1,2,5-噻二唑烷-3-酮 1,1-二氧化物 |
Phosphatase | Metabolism |
PTP1B-IN-1 (PTP1B inhibitor) 是一种蛋白质酪氨酸磷酸酶 1B 的有效抑制剂 (IC50 : 1.6 mM) | |||
T78702 |
PTP1B/AKR1B1-IN-1
|
Phosphatase | Metabolism |
PTP1B/AKR1B1-IN-1是一种针对PTP1B和AKR1B1的双重抑制剂,其IC50值分别为0.06 μM和4.3 μM。该化合物也能抑制TC-PTP,IC50为9 μM。在小鼠成肌细胞中,PTP1B/AKR1B1-IN-1作为胰岛素模拟剂使用,并能减少AKR1B1依赖的山梨醇积累,有助于抑制2型糖尿病的发展并控制血糖水平。 | |||
T7084 |
2-Bromo-4'-hydroxyacetophenone
SHP-1 Inhibitor II,PTP Inhibitor I,α-Bromo-4-hydroxyacetophenone,4-Hydroxyphenacyl bromide,2-溴-4'-羟基苯乙酮 |
Phosphatase | Metabolism |
2-Bromo-4'-hydroxyacetophenone(PTP Inhibitor I) 是一种PTP1B 的有效抑制剂,其Ki=42 μM。 | |||
T22276 |
Bis(maltolato)oxovanadium(IV)
双(麦芽醇)氧钒(IV),BMOV,Bis maltolato oxovanadium,Bis(maltolato)oxovanadium (IV),bis maltolato oxo vanadium,Bis(maltolato)oxovanadium (IV) |
Phosphatase; Others | Metabolism; Others |
Bis(maltolato)oxovanadium(IV) (BMOV) 是一种有效的胰岛素增敏剂,也是一种有效的、竞争性的、可逆的、口服具有活性的光谱蛋白酪氨酸磷酸酶 (PTP) 抑制剂。它抑制HCPTPA,PTP1B,HPTPβ和SHP2的IC50分别为 126 nM,109 nM,26 nM 和 201 nM。 | |||
T61851 | PTP1B-IN-3 diammonium | ||
PTP1B-IN-3 diammonium is a highly effective and orally bioavailable inhibitor of the protein tyrosine phosphatase 1B (PTP1B) enzyme, with an IC50 value of 120 nM for both PTP1B and TCPTP. This compound exhibits potent antidiabetic and anticancer properties, as supported by extensive research [1] [2]. | |||
T79844 |
Anticancer agent 143
|
Phosphatase | Metabolism |
Anticanceragent 143(化合物 369),作为PTPN2/PTP1B双重抑制剂,表现出强效活性,其IC50值均低于2.5 nM。该化合物主要用于癌症研究领域。 | |||
T78703 |
PTP1B/AKR1B1-IN-2
|
Phosphatase | Metabolism |
PTP1B/AKR1B1-IN-2(化合物7f)是一种双重PTP1B/AKR1B1抑制剂,具有IC50:3.2和2.1 μM,Ki:4.0和0.9μM。该化合物作为胰岛素模拟剂,能够改善小鼠C2C12肌母细胞的葡萄糖摄取,并可用于2型糖尿病(T2DM)的研究。 | |||
T35877 |
MurA-IN-1
|
||
MurA-IN-1 (compound 1a) is a PTPRR inhibitor, with IC50 values of 0.23 μM, 0.8 μM, 0.75 μM and 0.09 μM for PTP1B, PTPN5, PTPN7 and PTPRR, respectively[1]. (A family of human MAPK-specific protein tyrosine phosphatases) [1]. Jeyanthy Eswaran, et al. Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases. Biochem J. 2006 May 1;395(3):483-91. | |||
T79479 |
MptpB-IN-2
|
Antibiotic | Microbiology/Virology |
MptpB-IN-2(化合物20)是一种高选择性的结核分枝杆菌蛋白酪氨酸磷酸酶B(MptpB)抑制剂,其对MptpB、MptpA和PTP1B的IC50值分别为0.64 μM、4.06 μM和4.14 μM。此化合物对Mtb H37Rv表现出较低的抗结核活性,MIC为64.9 μM。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T75495 | Rubrofusarin 6-O-β-D-glucopyranoside | ||
Rubrofusarin 6-O-β-D-glucopyranoside为Rubrofusarin的糖苷形式,具有抑制蛋白酪氨酸磷酸酶 1B (PTP1B) 的活性,IC50值为87.36 μM,适用于糖尿病和抑郁症研究。 | |||
T80008 |
Stevisaliosides D
|
Phosphatase | Metabolism |
Stevisaliosides D (Compound 5) 是从甜叶菊根中提取的化合物,具有抑制PTP1B的活性(IC50:31.8 μM),应用于抗糖尿病研究。 | |||
T80007 |
Stevisalioside A
|
Phosphatase | Metabolism |
Stevisalioside A (Compound 2),一种从甜叶菊根提取的化合物,展现出抗糖尿病的口服活性。该化合物有效抑制PTP1B,IC50为526.8 μM,并能降低Stevisalioside A引起的高血糖小鼠血糖水平,改善餐后血糖峰值及口服葡萄糖和胰岛素耐量测试结果。 | |||
TN4064 |
Flavoglaucin
|
Phosphatase; IL Receptor; TNF; NOS; NF-κB; COX; Nrf2; Prostaglandin Receptor; Autophagy | Apoptosis; Autophagy; GPCR/G Protein; Immunology/Inflammation; Metabolism; Neuroscience; NF-κB |
Flavoglaucin exhibits significant inhibitory effects on PTP1B, the IC50 value of 13.4, micrometer; it also shows good binding affinity for human opioid or cannabinoid receptors. Flavoglaucin appears to be an antitumor promoter, it also has anti-inflammato |